WeVote
Log In

Bill

Bill

SB 236

Abortion inducing drugs and abortion reports.

2026 Regular Session Introduced by Scott Alexander and 17 co-sponsors

Indiana bill restricts medication abortion access and mandates abortion reporting, affecting drug distribution, provider practices, and patient privacy in early pregnancy terminations.

Senators Alexander, Holdman, Byrne added as coauthors
#agencies;departmentofhealth(idoh) #childrenandminors;crimesagainstchildren #childrenandminors;generally #civillawandprocedure;contractsandlegaldocuments #criminallawandprocedure;prosecutingattorneys(non-elected) #health;abortion #health;medicalrecords #health;pregnancy #health;prescriptiondrugsandmedications #publicrecords #stateelectedofficials;attorneygeneral
0
WeVote Research Nonpartisan
Bill Summary · SB 236

Legislative bill overview

SB 236 regulates medication abortion (mifepristone/misoprostol) in Indiana and establishes reporting requirements for abortion procedures. The bill appears to impose restrictions on how abortion-inducing drugs can be obtained and used, along with mandatory data collection and reporting obligations for healthcare providers.

Why is this important

Medication abortion accounts for over half of all abortions nationally and is a primary method used in early pregnancy. How states regulate these drugs significantly impacts abortion access, healthcare provider practices, and reproductive autonomy. The reporting requirements create documentation that affects privacy and may influence enforcement of abortion restrictions.

Potential points of contention

  • Drug access and physician involvement: Restrictions on medication abortion distribution may limit telemedicine options and require in-person medical supervision, affecting rural access and procedural convenience
  • Reporting requirements and privacy: Mandatory abortion reporting creates records that could be used for enforcement, prosecutions, or civil liability, raising privacy and potential prosecution concerns for both patients and providers
  • Conflict with federal law: Medication abortion access is currently protected under federal law; state restrictions face legal challenges regarding FDA-approved drug protocols and interstate pharmacy operations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.